Coffee grounds emesis

Rare presentation of testicular cancer treated with neoadjuvant chemotherapy

Jess L Thompson, Michael L. Blute

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Fewer than 5% of patients with metastatic testicular cancer present with gastrointestinal involvement. Even rarer is testicular metastasis to the duodenum. We present the case of a previously healthy 26-year-old man who had symptomatic gastrointestinal bleeding caused by metastatic testicular cancer. He was treated with orchiectomy, cisplatin-based neoadjuvant chemotherapy, and finally, resection of the residual retroperitoneal mass. We believe that neoadjuvant chemotherapy, followed by surgical debulking, is the appropriate therapeutic sequence when treating an otherwise stable patient with metastatic testicular tumor involving the gastrointestinal tract.

Original languageEnglish (US)
JournalUrology
Volume64
Issue number2
DOIs
StatePublished - Aug 2004
Externally publishedYes

Fingerprint

Coffee
Testicular Neoplasms
Vomiting
Drug Therapy
Orchiectomy
Duodenum
Cisplatin
Gastrointestinal Tract
Hemorrhage
Neoplasm Metastasis
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Coffee grounds emesis : Rare presentation of testicular cancer treated with neoadjuvant chemotherapy. / Thompson, Jess L; Blute, Michael L.

In: Urology, Vol. 64, No. 2, 08.2004.

Research output: Contribution to journalArticle

@article{c6fb2da44ddc4c28bd77adefe00c2a18,
title = "Coffee grounds emesis: Rare presentation of testicular cancer treated with neoadjuvant chemotherapy",
abstract = "Fewer than 5{\%} of patients with metastatic testicular cancer present with gastrointestinal involvement. Even rarer is testicular metastasis to the duodenum. We present the case of a previously healthy 26-year-old man who had symptomatic gastrointestinal bleeding caused by metastatic testicular cancer. He was treated with orchiectomy, cisplatin-based neoadjuvant chemotherapy, and finally, resection of the residual retroperitoneal mass. We believe that neoadjuvant chemotherapy, followed by surgical debulking, is the appropriate therapeutic sequence when treating an otherwise stable patient with metastatic testicular tumor involving the gastrointestinal tract.",
author = "Thompson, {Jess L} and Blute, {Michael L.}",
year = "2004",
month = "8",
doi = "10.1016/j.urology.2004.04.022",
language = "English (US)",
volume = "64",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Coffee grounds emesis

T2 - Rare presentation of testicular cancer treated with neoadjuvant chemotherapy

AU - Thompson, Jess L

AU - Blute, Michael L.

PY - 2004/8

Y1 - 2004/8

N2 - Fewer than 5% of patients with metastatic testicular cancer present with gastrointestinal involvement. Even rarer is testicular metastasis to the duodenum. We present the case of a previously healthy 26-year-old man who had symptomatic gastrointestinal bleeding caused by metastatic testicular cancer. He was treated with orchiectomy, cisplatin-based neoadjuvant chemotherapy, and finally, resection of the residual retroperitoneal mass. We believe that neoadjuvant chemotherapy, followed by surgical debulking, is the appropriate therapeutic sequence when treating an otherwise stable patient with metastatic testicular tumor involving the gastrointestinal tract.

AB - Fewer than 5% of patients with metastatic testicular cancer present with gastrointestinal involvement. Even rarer is testicular metastasis to the duodenum. We present the case of a previously healthy 26-year-old man who had symptomatic gastrointestinal bleeding caused by metastatic testicular cancer. He was treated with orchiectomy, cisplatin-based neoadjuvant chemotherapy, and finally, resection of the residual retroperitoneal mass. We believe that neoadjuvant chemotherapy, followed by surgical debulking, is the appropriate therapeutic sequence when treating an otherwise stable patient with metastatic testicular tumor involving the gastrointestinal tract.

UR - http://www.scopus.com/inward/record.url?scp=4143151897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143151897&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2004.04.022

DO - 10.1016/j.urology.2004.04.022

M3 - Article

VL - 64

JO - Urology

JF - Urology

SN - 0090-4295

IS - 2

ER -